Literature DB >> 30811922

Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer. Reply.

Leora Horn1, Stephen V Liu2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30811922     DOI： 10.1056/NEJMc1900123

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study.

Authors:  Vinicius Ernani; Rahat Jahan; Lynette M Smith; Alissa S Marr; Sarah E Kimbrough; Mary E Kos; Jolene Tijerina; Shannon Pivovar; Imayavaramban Lakshmanan; Marsha Ketcham; Sanchita Rauth; Kavita Mallya; Mohd W Nasser; Maneesh Jain; Anne Kessinger; Surinder K Batra; Apar Kishor Ganti
Journal:  Cancer Treat Res Commun       Date:  2019-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.